BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Z, Ren K, Zhang X, Chen J, Jiang Z, Jiang J, Ji F, Ouyang X, Li L. Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications. Engineering (Beijing) 2020. [PMID: 32904601 DOI: 10.1016/j.eng.2020.07.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Pereira E, Felipe S, de Freitas R, Araújo V, Soares P, Ribeiro J, Henrique Dos Santos L, Alves JO, Canabrava N, van Tilburg M, Guedes MI, Ceccatto V. ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms. Microb Pathog 2022;:105658. [PMID: 35764188 DOI: 10.1016/j.micpath.2022.105658] [Reference Citation Analysis]
2 Zeng C, Evans JP, King T, Zheng YM, Oltz EM, Whelan SPJ, Saif LJ, Peeples ME, Liu SL. SARS-CoV-2 spreads through cell-to-cell transmission. Proc Natl Acad Sci U S A 2022;119:e2111400119. [PMID: 34937699 DOI: 10.1073/pnas.2111400119] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
3 Huang C, Tan Z, Zhao K, Zou W, Wang H, Gao H, Sun S, Bu D, Chai W, Li Y. The effect of N-glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor. iScience 2021;24:103272. [PMID: 34661088 DOI: 10.1016/j.isci.2021.103272] [Reference Citation Analysis]
4 Rangel-Angarita V, Malaker SA. Mucinomics as the Next Frontier of Mass Spectrometry. ACS Chem Biol 2021;16:1866-83. [PMID: 34319686 DOI: 10.1021/acschembio.1c00384] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mohsen MO, Rothen D, Balke I, Martina B, Zeltina V, Inchakalody V, Gharailoo Z, Nasrallah G, Dermime S, Tars K, Vogel M, Zeltins A, Bachmann MF. Neutralization of MERS coronavirus through a scalable nanoparticle vaccine. NPJ Vaccines 2021;6:107. [PMID: 34429427 DOI: 10.1038/s41541-021-00365-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fluckiger AC, Ontsouka B, Bozic J, Diress A, Ahmed T, Berthoud T, Tran A, Duque D, Liao M, McCluskie M, Diaz-Mitoma F, Anderson DE, Soare C. An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity. Vaccine 2021;39:4988-5001. [PMID: 34304928 DOI: 10.1016/j.vaccine.2021.07.034] [Reference Citation Analysis]
7 Patil VS, Hupparage VB, Malgi AP, Deshpande SH, Patil SA, Mallapur SP. Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera. Chin Herb Med 2021;13:359-69. [PMID: 34188665 DOI: 10.1016/j.chmed.2021.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zeng C, Evans JP, King T, Zheng YM, Oltz EM, Whelan SPJ, Saif L, Peeples ME, Liu SL. SARS-CoV-2 Spreads through Cell-to-Cell Transmission. bioRxiv 2021:2021. [PMID: 34100011 DOI: 10.1101/2021.06.01.446579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Griffin JH, Downard KM. Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review. Trends Analyt Chem 2021;142:116328. [PMID: 33994605 DOI: 10.1016/j.trac.2021.116328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ahsan N, Rao RSP, Wilson RS, Punyamurtula U, Salvato F, Petersen M, Ahmed MK, Abid MR, Verburgt JC, Kihara D, Yang Z, Fornelli L, Foster SB, Ramratnam B. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches. Proteomics 2021;21:e2000279. [PMID: 33860983 DOI: 10.1002/pmic.202000279] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
11 Casalino L, Dommer AC, Gaieb Z, Barros EP, Sztain T, Ahn S, Trifan A, Brace A, Bogetti AT, Clyde A, Ma H, Lee H, Turilli M, Khalid S, Chong LT, Simmerling C, Hardy DJ, Maia JD, Phillips JC, Kurth T, Stern AC, Huang L, Mccalpin JD, Tatineni M, Gibbs T, Stone JE, Jha S, Ramanathan A, Amaro RE. AI-driven multiscale simulations illuminate mechanisms of SARS-CoV-2 spike dynamics. The International Journal of High Performance Computing Applications 2021;35:432-51. [DOI: 10.1177/10943420211006452] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
12 Segreto R, Deigin Y, McCairn K, Sousa A, Sirotkin D, Sirotkin K, Couey JJ, Jones A, Zhang D. Should we discount the laboratory origin of COVID-19? Environ Chem Lett 2021;:1-15. [PMID: 33786037 DOI: 10.1007/s10311-021-01211-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
13 Breiman A, Ruvoën-Clouet N, Deleers M, Beauvais T, Jouand N, Rocher J, Bovin N, Labarrière N, El Kenz H, Le Pendu J. Low Levels of Natural Anti-α-N-Acetylgalactosamine (Tn) Antibodies Are Associated With COVID-19. Front Microbiol 2021;12:641460. [PMID: 33643275 DOI: 10.3389/fmicb.2021.641460] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Bittremieux W, Adams C, Laukens K, Dorrestein PC, Bandeira N. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2. J Proteome Res 2021;20:1464-75. [PMID: 33605735 DOI: 10.1021/acs.jproteome.0c00929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Takeda Y, Jamsransuren D, Matsuda S, Crea R, Ogawa H. The SARS-CoV-2-Inactivating Activity of Hydroxytyrosol-Rich Aqueous Olive Pulp Extract (HIDROX®) and Its Use as a Virucidal Cream for Topical Application. Viruses 2021;13:232. [PMID: 33540713 DOI: 10.3390/v13020232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
16 Badawi S, Ali BR. ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues. Hum Genomics 2021;15:8. [PMID: 33514423 DOI: 10.1186/s40246-021-00304-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
17 Pendu JL, Breiman A, Rocher J, Dion M, Ruvoën-Clouet N. ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data. Viruses 2021;13:160. [PMID: 33499228 DOI: 10.3390/v13020160] [Cited by in Crossref: 13] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
18 Bachmann MF, Mohsen MO, Zha L, Vogel M, Speiser DE. SARS-CoV-2 structural features may explain limited neutralizing-antibody responses. NPJ Vaccines 2021;6:2. [PMID: 33398006 DOI: 10.1038/s41541-020-00264-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
19 Deleers M, Breiman A, Daubie V, Maggetto C, Barreau I, Besse T, Clémenceau B, Ruvoën-Clouet N, Fils JF, Maillart E, Doyen V, Mahadeb B, Jani JC, Van der Linden P, Cannie MM, Hayef N, Corazza F, Le Pendu J, El Kenz H. Covid-19 and blood groups: ABO antibody levels may also matter. Int J Infect Dis 2021;104:242-9. [PMID: 33326874 DOI: 10.1016/j.ijid.2020.12.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
20 Dollman NL, Griffin JH, Downard KM. Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry. ACS Infect Dis 2020;6:3269-76. [PMID: 33205948 DOI: 10.1021/acsinfecdis.0c00664] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
21 Casalino L, Dommer A, Gaieb Z, Barros EP, Sztain T, Ahn SH, Trifan A, Brace A, Bogetti A, Ma H, Lee H, Turilli M, Khalid S, Chong L, Simmerling C, Hardy DJ, Maia JDC, Phillips JC, Kurth T, Stern A, Huang L, McCalpin J, Tatineni M, Gibbs T, Stone JE, Jha S, Ramanathan A, Amaro RE. AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics. bioRxiv 2020:2020. [PMID: 33236007 DOI: 10.1101/2020.11.19.390187] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
22 Alhalaili B, Popescu IN, Kamoun O, Alzubi F, Alawadhia S, Vidu R. Nanobiosensors for the Detection of Novel Coronavirus 2019-nCoV and Other Pandemic/Epidemic Respiratory Viruses: A Review. Sensors (Basel) 2020;20:E6591. [PMID: 33218097 DOI: 10.3390/s20226591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
23 Barros EP, Casalino L, Gaieb Z, Dommer AC, Wang Y, Fallon L, Raguette L, Belfon K, Simmerling C, Amaro RE. The flexibility of ACE2 in the context of SARS-CoV-2 infection. Biophys J 2021;120:1072-84. [PMID: 33189680 DOI: 10.1016/j.bpj.2020.10.036] [Cited by in Crossref: 32] [Cited by in F6Publishing: 57] [Article Influence: 16.0] [Reference Citation Analysis]
24 Duan L, Zheng Q, Zhang H, Niu Y, Lou Y, Wang H. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens. Front Immunol 2020;11:576622. [PMID: 33117378 DOI: 10.3389/fimmu.2020.576622] [Cited by in Crossref: 69] [Cited by in F6Publishing: 117] [Article Influence: 34.5] [Reference Citation Analysis]
25 Barros EP, Casalino L, Gaieb Z, Dommer AC, Wang Y, Fallon L, Raguette L, Belfon K, Simmerling C, Amaro RE. The flexibility of ACE2 in the context of SARS-CoV-2 infection. bioRxiv 2020:2020. [PMID: 32995769 DOI: 10.1101/2020.09.16.300459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
26 Speiser DE, Bachmann MF. COVID-19: Mechanisms of Vaccination and Immunity. Vaccines (Basel) 2020;8:E404. [PMID: 32707833 DOI: 10.3390/vaccines8030404] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 11.5] [Reference Citation Analysis]
27 Zecha J, Lee CY, Bayer FP, Meng C, Grass V, Zerweck J, Schnatbaum K, Michler T, Pichlmair A, Ludwig C, Kuster B. Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing. Mol Cell Proteomics 2020;19:1503-22. [PMID: 32591346 DOI: 10.1074/mcp.RA120.002164] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]